Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
U.S. stocks traded lower this morning, with the Dow Jones index dipping more than 250 points on Wednesday.
今天上午美國股市走低,道瓊斯指數週三下跌超過250點。
Following the market opening Wednesday, the Dow traded down 0.63% to 42,654.26 while the NASDAQ fell 0.47% to 18,486.46. The S&P 500 also fell, dropping, 0.33% to 5,831.63.
週三開盤後,道瓊斯指數下跌0.63%,至42,654.26點,而納斯達克指數下跌0.47%,至18,486.46。標準普爾500指數也下跌了0.33%,至5,831.63點。
Leading and Lagging Sectors
Utilities shares rose by 0.5% on Wednesday.
領先和落後行業
週三,公用事業股上漲0.5%。
In trading on Wednesday, consumer discretionary shares fell by 0.9%.
在週三的交易中,非必需消費品股下跌0.9%。
Top Headline
熱門標題
Boeing Co (NYSE:BA) reported a loss for the third quarter on Wednesday.
波音公司(紐約證券交易所代碼:BA)週三公佈了第三季度虧損。
The company posted a 1% year-over-year revenue decline to $17.854 billion in the third quarter of 2024, missing the consensus of $17.931 billion. Adjusted loss per share expanded to $10.44 from $3.62 in the same quarter of 2023, missing the consensus of $10.34.
該公司在2024年第三季度公佈的收入同比下降1%,至178.54億美元,未達到預期的179.31億美元。調整後的每股虧損從2023年同期的3.62美元擴大至10.44美元,未達到10.34美元的共識。
Equities Trading UP
股票交易上漲
- La Rosa Holdings Corp. (NASDAQ:LRHC) shares shot up 164% to $1.3300 after the company reported preliminary 9-moth revenue growth of 120% year over year.
- Shares of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) got a boost, surging 90% to $0.2979. The company requested a panel hearing for November 5, 2024, and will be subject to a halt in the suspension or delisting decision until then.
- Virax Biolabs Group Limited (NASDAQ:VRAX) shares were also up, gaining 87% to $3.1197 after the company announced a distribution agreement with Europa Biosite to commercialize the ImmuneSelect research-use portfolio in the United Kingdom and Ireland.
- 拉羅莎控股公司(納斯達克股票代碼:LRHC)股價飆升164%,至1.3300美元,此前該公司報告9個月的初步收入同比增長120%。
- CNS製藥公司(納斯達克股票代碼:CNSP)的股價上漲,飆升90%,至0.2979美元。該公司要求在2024年11月5日舉行小組聽證會,在此之前,暫停或退市的決定將暫停。
- Virax Biolabs集團有限公司(納斯達克股票代碼:VRAX)股價也上漲了87%,至3.1197美元,此前該公司宣佈與Europa Biosite簽訂分銷協議,將ImmuneSelect在英國和愛爾蘭的研究用途組合商業化。
Equities Trading DOWN
股票交易下跌
- Alto Neuroscience, Inc. (NYSE:ANRO) shares dropped 62% to $5.53 after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.
- Shares of Ensysce Biosciences, Inc. (NASDAQ:ENSC) were down 26% to $0.3960.
- Aptevo Therapeutics Inc. (NASDAQ:APVO) was down, falling 26% to $0.2616.
- Alto Neuroscience, Inc.(紐約證券交易所代碼:ANRO)股價下跌62%,至5.53美元,此前該公司公佈了一項評估 ALTO-100 作爲重度抑鬱症治療方法的20年期試驗的主要結果未達到其主要終點。
- Ensysce Biosciences, Inc.(納斯達克股票代碼:ENSC)的股價下跌26%,至0.3960美元。
- Aptevo Therapeutics Inc.(納斯達克股票代碼:APVO)下跌26%,至0.2616美元。
Commodities
In commodity news, oil traded down 1.3% to $70.80 while gold traded down 0.5% at $2,747.40.
大宗商品
在大宗商品新聞方面,石油價格下跌1.3%,至70.80美元,而黃金下跌0.5%,至2747.40美元。
Silver traded down 2.5% to $34.180 on Wednesday, while copper fell 1.3% to $4.3240.
週三,白銀下跌2.5%,至34.180美元,而銅價下跌1.3%,至4.3240美元。
Euro zone
歐元區
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.2%, Germany's DAX fell 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 fell 0.5%.
今天歐洲股市大多走低。歐元區斯托克600指數下跌0.2%,德國DAX指數下跌0.2%,法國CAC 40指數下跌0.5%。西班牙的IBEX 35指數上漲0.1%,而倫敦富時100指數下跌0.5%。
Asia Pacific Markets
亞太市場
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.80%, Hong Kong's Hang Seng Index gaining 1.27%, China's Shanghai Composite Index gaining 0.52% and India's BSE Sensex falling 0.17%.
週三亞洲市場收盤漲跌互現,日本日經225指數下跌0.80%,香港恒生指數上漲1.27%,中國上證綜合指數上漲0.52%,印度BSE Sensex下跌0.17%。
Singapore's annual inflation rate eased to 2.0% in September versus 2.2% in the previous month.
新加坡9月份的年通貨膨脹率從上個月的2.2%降至2.0%。
Economics
經濟學
U.S. mortgage applications declined by 6.7% from the previous week during the third week of October, following a 17% dip in the earlier period.
繼前一段時間下降17%之後,10月第三週美國抵押貸款申請較前一週下降了6.7%。
Now Read This:
現在讀這個:
- Top 2 Energy Stocks That May Implode This Quarter
- 本季度可能暴跌的兩大能源股